Up next
Author
Tags

As of Wednesday noon (26 May), the Ministry of Health (MOH) has preliminarily confirmed an additional 26 cases of COVID-19 infection in Singapore.

This brings the total number of infection cases to 61,916.

There are 24 new cases of locally transmitted COVID-19 infection. 21 are linked to previous cases, amongst which 14 have already been placed on quarantine, and seven were detected through surveillance.

“The remaining 3 are currently unlinked,” said MOH.

“Based on our investigations so far, 23 are in the community, and 1 resides in a dormitory.”

In addition, there are two new imported cases, who had been placed on Stay-Home Notice (SHN) upon arrival in Singapore.

The Ministry will share further updates in its press release tonight.

According to last night’s press release, there are currently 250 confirmed cases who are still in hospital. Of these, most are stable or improving, and two are in critical condition in the intensive care unit (ICU).

279 are isolated and cared for at community facilities. These are those who have mild symptoms, or are clinically well but still test positive for COVID-19.

32 have passed away from complications due to COVID-19 infection.

Subscribe
Notify of
4 Comments
Newest
Oldest Most Voted
Inline Feedbacks
View all comments
You May Also Like

World Health Organization officially classifies artificial sweetener “aspartame” as a carcinogen

The World Health Organization (WHO), through its International Agency for Research on Cancer (IARC), has officially classified aspartame, a widely used artificial sweetener, as a potential carcinogen. This suggests that it could pose a risk for causing cancer in humans. However, the acceptable daily intake limit for aspartame remains at 40 milligrams per kilogram of body weight. This standard has been reaffirmed by the Joint Expert Committee on Food Additives (JECFA), a scientific advisory body jointly administered by the Food and Agriculture Organization (FAO) of the United Nations.

M’sian workers returning to SG will serve a 7-day SHN because COVID-19 symptoms show within 5-6 days and M’sia has lower prevalence of Covid-19

Based on the data from the Ministry of Health (MOH), findings showed…

EU approves first vaccine against common respiratory virus

The European Commission has approved the world’s first vaccine for Respiratory Syncytial Virus (RSV) in adults aged 60 and over. GSK, the maker of the vaccine called Arexvy, stated that this authorization allows eligible adults to be vaccinated against RSV for the first time. RSV can cause severe illness in vulnerable populations and has led to approximately 20,000 in-hospital deaths each year in Europe among adults aged 60 and over. The market for RSV vaccines is projected to exceed $10 billion in the coming decade.